Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines

Genes Chromosomes and Cancer

Volumn 27, Issue 1, 2000, Pages 110-116

  Knutsen, Turid ^a,c   Koneti Rao, V ^a   Ried, Thomas ^a   Mickley, Lyn ^a   Schneider, Erasmus ^b   Miyake, Keisuke ^a   Michael Ghadimi, B ^a   Padilla Nash, Hesed ^a   Pack, Svetlana ^c   Greenberger, Lee ^d   Cowan, Kenneth ^a   Dean, Michael ^e   Fojo, Tito ^a   Bates, Susan ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WADSWORTH CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d PFIZER INC   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DOXORUBICIN; MITOXANTRONE;

ARTICLE; CANCER CELL; CHROMOSOME 4Q; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DRUG TRANSPORT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; KARYOTYPING; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARRIER PROTEINS; CHROMOSOME MAPPING; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 4; COLONIC NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE AMPLIFICATION; GENES, MDR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MITOXANTRONE; NUCLEIC ACID HYBRIDIZATION; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0033990247     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200001)27:1<110::AID-GCC14>3.0.CO;2-4     Document Type: Article

References (25)

1. Allikmets R, Gerrard B, Hutchinson A, Dean M. 1996. Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the Expressed Sequence Tags database. Hum Mol Genet 5:1649-1655.
2. Allikmets R, Schriml, LM, Hutchinson A, Romano-Spica V, Dean M. 1998. A human placenta-specific ATP-binding casssette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 58:5337-5339.
3. Borst P, Kool M, Evers R. 1997. Do cMOAT (MRP2), other MRP homologues and LRP play a role in MDR? Cancer Biol 8:205-213.
4. Chen Y-N, Mickley LA, Schwartz AM, Acton EM, Hwang J, Fojo AT. 1990. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein. J Biol Chem 265:10073-10080
5. Cole SPC, Bharedwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654.
6. Dalton WS, Cress AE, Alberts DS, Trent JM. 1988. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Cancer Res 48:1882-1888.
7. Dean M, Allikmets R. 1995. Evolution of ATP-binding cassette transporter genes. Curr Opin Genet Dev 5:779-785.
8. Dietel M, Arps H, Lage H, Niendorf A. 1990. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res 50:6100-6106.
9. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD. 1998. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95:15665-15670.
10. du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T. 1993. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590-610.
11. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D. 1996. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 56:988-994.
12. Juliano RL, Ling V. 1976. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 455:152-162.
13. Knutsen T, Mickley LA, Ried T, Green ED, du Manoir S, Schröck E, Macville M, Ning Y, Robey R, Polymeropoulos M, Torres R, Fojo T. 1998. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL. Genes Chromosomes Cancer 23:44-54.
14. Koike K, Kawabe T, Tanaka T, Toh S, Uchiumi T, Wada M, Akiyama S, Ono M, Kuwano M. 1997. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res 57:5475-5479.
15. Lee JS, Scala S, Matsumoto Y, Dickstein B, Robey R, Zhan Z, Altenberg G, Bates SE. 1997. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression. J Cell Biochem 65:513-526.
16. Mickley LA, Spengler BA, Knutsen TA, Biedler JL, Fojo T. 1997. Gene rearrangement: a novel mechanism for MDR1 gene activation. J Clin Invest 99:1947-1957.
17. Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, Bates SE. 1999. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes. Cancer Res 59:8-13.
18. Nakagawa M, Schneider E, Dixon KH, Horton J, Kelley K, Morrow C, Cowan KH. 1992. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 human breast cancer cells. Cancer Res 52:6175-6181.
19. Rabindran SK, He H, Singh M, Brown E, Collins KI, Annable T, Greenberger LM. 1998. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res 58:5850-5858.
20. Sandor V, Fojo T, Bates SE. 1998. Future perspectives for the development of P-glycoprotein modulators. Drug Resist Update 1:190-200.
21. Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. 1996. Multicolor spectral karyotyping of human chromosomes. Science 26:494-497.
22. Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM. 1986. Human multidrug-resistant cell lines: increased mdr-1 expression can precede gene amplification. Science 232:643-645.
23. Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, Kagotani K, Okumura K, Akiyama S, Kuwano M. 1996. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56:4124-4129.
24. Taylor CW, Dalton WS, Parrish PR, Gleason MC, Bellamy WT, Thompson FH, Roe DJ, Trent JM. 1991. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br J Cancer 63:923-929.
25. Yang C-HJ, Horton JK, Cowan K, Schneider F. 1995. Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell line is not due to DNA topoisomerase I alterations. Cancer Res 55:4004-4009.